fda warning compounding semaglutide october 2025 Sends Letters to More Than 50 GLP-1 Compounders and Manufacturers Compounded Semaglutide: Legal & Safe

Secure Communication Encrypted HIPAA-compliant video Secure provider messaging Lab result delivery & review Prescription tracking & refills Daily Tracking Log meals & water intake Monitor weight & measurements View progress charts & trends Access nutrition plan & recipes Available on iPhone and Android

No evidence of increase in calcitonin concentrations or development of c-cell malignancy in response to liraglutide for up to 5 years in the LEADER trial

The first two are approved to treat type 2 diabetes and used off-label for weight loss

Originally developed for managing type 2 diabetes, semaglutide GLP-1 has shown exceptional results in reducing body weight, leading to its approval for this purpose

However, many insurance plans cover the medication, either partially or fully

The USA leads through payer and employer workflows